60 Degrees Pharmaceuticals Investor Relations Material

60 Degrees Pharmaceuticals Inc. is a pharmaceutical company focused on developing and commercializing treatments for infectious diseases, particularly those affecting travelers and people in tropical and subtropical regions. The company’s primary focus is on therapeutics for diseases such as malaria and dengue fever, aiming to address unmet needs in global health. 60 Degrees Pharmaceuticals collaborates with various research organizations and government agencies to advance its product pipeline and expand access to its treatments in underserved regions. The company is headquartered in Washington, D.C., and its shares are listed on the NASDAQ.